Search International and National Patent Collections

1. (WO2013114413) DIETHYL- [6- (4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL) - NAPHTHALEN-2-YL-METHYL] -AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY

Pub. No.:    WO/2013/114413    International Application No.:    PCT/IT2012/000040
Publication Date: Fri Aug 09 01:59:59 CEST 2013 International Filing Date: Sat Feb 04 00:59:59 CET 2012
IPC: A61K 31/167
A61K 31/325
A61K 31/573
A61K 9/00
A61K 9/10
A61K 9/14
A61K 9/16
A61K 9/20
A61K 9/48
A61P 21/00
Applicants: ITALFARMACO S.P.A.
SACCONE, Valentina
CONSALVI, Silvia
PURI, Pier Lorenzo
MASCAGNI, Paolo
Inventors: SACCONE, Valentina
CONSALVI, Silvia
PURI, Pier Lorenzo
MASCAGNI, Paolo
Title: DIETHYL- [6- (4-HYDROXYCARBAMOYL-PHENYL-CARBAMOYLOXY-METHYL) - NAPHTHALEN-2-YL-METHYL] -AMMONIUM CHLORIDE FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY
Abstract:
The present invention relates to a method for treating muscular dystrophy which comprises administering diethyl- [ 6- ( 4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl ) - naphthalen-2-yl-methyl ] -ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof to a patient in need of such a treatment. The invention further relates to a method for treating muscular dystrophy which comprises administering diethyl- [ 6- ( 4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl ) - naphthalen-2-yl-methyl ] -ammonium chloride or other pharmaceutically acceptable' salts and/or solvates thereof in combination, with one or more additional anti-inflammatory active agents to a patient in need of such a treatment.